Status:

UNKNOWN

Prostate Cancer Secondary Screening in Sapienza and Policlinico Umberto I

Lead Sponsor:

University of Roma La Sapienza

Conditions:

Prostate Cancer (Diagnosis)

Eligibility:

MALE

40-69 years

Phase:

NA

Brief Summary

Prostate Cancer (PCa) screening is still a controversial topic in the urology community, this is mostly linked to the low specificity of Prostate Specific Antigen (PSA) value. Screening with total PSA...

Detailed Description

ENDPOINTS Primary endpoint To investigate the role of non-contrast Magnetic Resonance Imaging (MRI), as a secondary prevention test for the early diagnosis of prostate cancer (PCa), comparing it with ...

Eligibility Criteria

Inclusion

  • Inclusion criteria:
  • Males aged between 49-69 years (from the age of 40 for those with family history of prostate cancer) at the time of enrollment
  • Life expectancy greater than or equal to 10 years
  • Sufficient understanding of the Italian language for written and verbal understanding of the information for enrollment in the Trial and for the process of obtaining informed consent.
  • Patient with the ability to understand and want, able to express informed consent and to perform all the visits and procedures required by the study
  • Exclusion criteria:
  • General contraindications to MRI
  • Previous history of prostate cancer, prostate biopsy or treatment for prostate cancer
  • Any contraindications to prostate biopsy, such as severe coagulation abnormalities (INR\> 1.5), active urinary tract infection and acute prostatitis (NIH category I, II and III).
  • Dementia or altered mental status that would prohibit understanding or granting informed consent

Exclusion

    Key Trial Info

    Start Date :

    September 21 2020

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ESTIMATED

    End Date :

    September 1 2022

    Estimated Enrollment :

    710 Patients enrolled

    Trial Details

    Trial ID

    NCT04803188

    Start Date

    September 21 2020

    End Date

    September 1 2022

    Last Update

    March 17 2021

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Sapienza University of Rome

    Rome, Roma, Italy, 00185